跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 16,678 条关于
“Intract Pharma”
全部
16,678
临床试验
10,665
药物
1,388
机构
1,231
资讯
3,394
去年
Tharimmune Reports Breakthrough in Oral Delivery of TNF-α Inhibitor for Inflammatory Diseases
去年
Tharimmune's TH104 Advances to Phase 2 for Pruritus in Primary Biliary Cholangitis
去年
Tharimmune Advances TH104 as National Security Solution Against Weaponized Fentanyl, Secures $5.47M Funding
去年
NRx Pharmaceuticals' NRX-100 (Ketamine) Achieves Stability Milestone, NDA Filing on Track
上个月
Royalty Pharma and Zealand Pharma enter $100 million rusfertide funding agreement
去年
FDA Approves Verona Pharma's Ohtuvayre (ensifentrine) for COPD Maintenance
去年
RedHill Biopharma and Duke University Collaborate to Develop Opaganib for Phosgene Inhalation Injury
去年
EU Clinical Trial Regulation Transition: Sponsors Adapt as Deadline Looms
去年
Nxera Pharma Partners with Holling Bio-Pharma to Launch Daridorexant for Insomnia in Taiwan
去年
Calluna Pharma Appoints Mark Gaffney as CEO, Advances CAL101 Program
第 1 页,共 340 页
上一页
下一页